Health Care Costs Associated with Addition, Titration, and Switching Antihypertensive Medications After First-Line Treatment: Results from a Commercially Insured Sample-Reference-Cited by-同舟云学术

Health Care Costs Associated with Addition, Titration, and Switching Antihypertensive Medications After First-Line Treatment: Results from a Commercially Insured Sample

Published:2017-06 Issue:6 Volume:23 Page:691-699
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Deshmukh Kalyani B. Sonawane¹,Qian Jingjing²,Garza Kimberly B.²,Wright Bradley M.³,Zeng Peng⁴,Cazaban Cecilia M. Ganduglia⁵,Hansen Richard A.²

Affiliation:

1. Health Services Research, Management and Policy, University of Florida, Gainesville.

2. Health Outcomes Research and Policy, Auburn University, Auburn, Alabama.

3. Pharmacy Practice, Auburn University, Auburn, Alabama, and Internal Medicine, University of Alabama at Birmingham.

4. Mathematics and Statistics, Auburn University, Auburn, Alabama.

5. Management, Policy and Community Health, The University of Texas Health Science Centre at Houston.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction;Current Cardiology Reports;2023-11-22

2. Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and Challenges;Current Hypertension Reports;2020-10-14

3. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries;Expert Review of Pharmacoeconomics & Outcomes Research;2020-01-02